Bausch Lomb Ireland Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH LOMB IRELAND, and when can generic versions of BAUSCH LOMB IRELAND drugs launch?
BAUSCH LOMB IRELAND has three approved drugs.
There are three US patents protecting BAUSCH LOMB IRELAND drugs.
There are four patent family members on BAUSCH LOMB IRELAND drugs in four countries and four supplementary protection certificates in four countries.
Summary for Bausch Lomb Ireland
| International Patents: | 4 |
| US Patents: | 3 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Bausch Lomb Ireland
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bausch Lomb Ireland | TETRACAINE HYDROCHLORIDE | tetracaine hydrochloride | SOLUTION;OPHTHALMIC | 210821-001 | Mar 12, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | 10,632,197 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Bausch Lomb Ireland | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | benoxinate hydrochloride; fluorescein sodium | SOLUTION/DROPS;OPHTHALMIC | 211039-001 | Mar 9, 2020 | RX | Yes | Yes | 10,293,047 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bausch Lomb Ireland
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 4,833,790 | ⤷ Sign Up |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,095,030 | ⤷ Sign Up |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,214,036 | ⤷ Sign Up |
| Bausch Lomb Ireland | VISUDYNE | verteporfin | INJECTABLE;INJECTION | 021119-001 | Apr 12, 2000 | 5,756,541 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bausch Lomb Ireland Drugs
Supplementary Protection Certificates for Bausch Lomb Ireland Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0352076 | SPC/GB01/005 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: VERTEPORFIN OPTIONALLY IN THE FORM OF A SALT THEREOF; REGISTERED: UK EU/1/00/140/001 20000727 |
| 0352076 | 2001C/010 | Belgium | ⤷ Sign Up | PRODUCT NAME: VERTEPORFIN; NAT. REGISTRATION NO./DATE: EU/1/00/140/001 20000727; FIRST REGISTRATION: CH 55269 19991215 |
| 0352076 | 1/2001 | Austria | ⤷ Sign Up | PRODUCT NAME: VERTEPORFIN; REGISTRATION NO/DATE: EU/1/00/140/001 20000727 |
| 0352076 | C300037 | Netherlands | ⤷ Sign Up | PRODUCT NAME: VERTEPORFINE, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/00/140/001 20000727 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
